Cognitive Assessment in COVID-19 Positive Patients Using the DANA App

Completed

Conditions studied: COVID-19

In brief

The Defense Automated Neurobehavioral Assessment (DANA) is a battery of cognitive tests delivered via an electronic tablet or smartphone. The overarching goal of this study is to evaluate the post-acute trajectory of cognitive functioning in patients hospitalized for COVID-19 using the DANA.

Key facts

Study ID

NCT05143333

Run by

Johns Hopkins University

People needed

28

Starts

2021-07-01

Expected to finish

2021-12-31

Last updated by the study team

2022-01-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have documented pulmonary illness treated in the PACT clinic.
• Have access to an internet-connected electronic device (e.g., Android or iOS phone or tablet) able to perform DANA.
• Agree to participate in seven DANA assessments.
• Be proficient in use of the English language.
• Willing and able to consent to the study.

You may not qualify if…

• During the testing phase, plans to undergo treatment with documented lasting neurocognitive effects that will confound DANA assessments, including but not limited to: neurosurgery, chemotherapy, radiation therapy, electroconvulsive therapy, and cardiac surgery.
• During the testing phase, sustains injury or disease state unrelated to reason for PACT admission with documented lasting neurocognitive effects that will confound DANA assessments, including but not limited to: traumatic brain injury (as determined by study clinician).

Where it is running

• Johns Hopkins Psychiatry department — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.